- Lobbying
- Lobbying by Complete Pharma Holdings LLC
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Laura Johnson | Legislative Intern - Senate HELP Committee |
Alfred Mottur | Sr Commun Counsel-Senate Commerce Comm Communications Counsel-Sen. Commerce Com Law Clerk-Federal District Court-Bangor, ME |
William Moschella | PrinAssocDepAG DOJ,AsstAG DOJ,ChfLegCouns/Parliam Hs Judic Comm,ChfInvestigativeCouns Hs Judic Comm, GC Hs Rule Comm,Couns Hs Judic Comm,Couns/Parliam Hs Gov Rel Comm, SrLegAssst Rep Frank Wolf,LegAsst Rep Frank Wolf,ComputerSysManager Rep Frank Wolf |
Cate McCanless | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate,
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Pharmaceutical issues regarding rare diseases
Reimbursement issues.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate